Skip to content
MedsAcross

Manufacturer

i3 Pharmaceuticals

Products listed
19
Molecules
12
Therapy areas
10

i3 Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 19 of its products across 12 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
i3 Pharmaceuticals, LLC
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply i3 Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Oncology

4 presentations

Oncology overview
MedicineActive ingredientRegisterAvailability
Everolimus 0.25 mg tabletOralGeneric nameEverolimusUS FDAAvailable on request
Everolimus 0.5 mg tabletOralGeneric nameEverolimusUS FDAAvailable on request
Everolimus 0.75 mg tabletOralGeneric nameEverolimusUS FDAAvailable on request
Everolimus 1 mg tabletOralGeneric nameEverolimusUS FDAAvailable on request

Cardiology

4 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Guanfacine 1 mg tabletOralGeneric nameGuanfacineUS FDAAvailable on request
Guanfacine 2 mg tabletOralGeneric nameGuanfacineUS FDAAvailable on request
Ranolazine 1000 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request
Ranolazine 500 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request

HIV

2 presentations

HIV overview
MedicineActive ingredientRegisterAvailability
Maraviroc 150 mg tabletOralGeneric nameMaravirocUS FDAAvailable on request
Maraviroc 300 mg tabletOralGeneric nameMaravirocUS FDAAvailable on request

Ophthalmology

2 presentations

Ophthalmology overview
MedicineActive ingredientRegisterAvailability
Methscopolamine 2.5 mg tabletOralGeneric nameMethscopolamineUS FDAAvailable on request
Methscopolamine 5 mg tabletOralGeneric nameMethscopolamineUS FDAAvailable on request

Antibiotics

1 presentation

Antibiotics overview
MedicineActive ingredientRegisterAvailability
Clindamycin 10 mg/mL topical solutionTopicalGeneric nameClindamycinUS FDAAvailable on request

Antifungals

1 presentation

Antifungals overview
MedicineActive ingredientRegisterAvailability
Posaconazole 100 mg delayed-release tabletOralGeneric namePosaconazoleUS FDAAvailable on request

Psychiatry

1 presentation

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Ramelteon 8 mg tabletOralGeneric nameRamelteonUS FDAAvailable on request

Tuberculosis

1 presentation

Tuberculosis overview
MedicineActive ingredientRegisterAvailability
Rifabutin 150 mg capsuleOralGeneric nameRifabutinUS FDAAvailable on request

Neurology

1 presentation

Neurology overview
MedicineActive ingredientRegisterAvailability
Selegiline 5 mg tabletOralGeneric nameSelegilineUS FDAAvailable on request

Haematology

1 presentation

Haematology overview
MedicineActive ingredientRegisterAvailability
Tranexamic acid 650 mg tabletOralGeneric nameTranexamic acidUS FDAAvailable on request

Other products

1 presentation

MedicineActive ingredientRegisterAvailability
Hydralazine and Isosorbide dinitrate 37.5 mg/20 mg tabletOralGeneric nameHydralazine and Isosorbide dinitrateUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from i3 Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.